Ledger.Open graph →
SEC Form D · filed September 21, 2021

bluebird bio, Inc

Offering
$75.0M
Sold
$75.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Daniel S. Lynch · Cambridge, MADirectorNick S. Leschly · Cambridge, MAExec · DirectorDaniel S. Lynch · Cambridge, MADirectorRamy S. Ibrahim · Cambridge, MADirectorJason Cole · Cherry Hill, NJExecMark R. Vachon · Cambridge, MADirectorChip Baird · New York, NYExecJohn S. Agwunobi · Cambridge, MADirectorDenice R. Torres · Cambridge, MADirectorWilliam R. Sellers · Cambridge, MADirectorWendy S. Dixon · Cambridge, MADirectorDaniel S. Lynch · Stamford, CTDirectorRamy S. Ibrahim · Cambridge, MADirectorJason Cole · Cambridge, MAExecMark R. Vachon · Cambridge, MADirectorChip Baird · Redding, CAExecJohn S. Agwunobi · Cambridge, MADirectorDenice R. Torres · Cambridge, MADirectorWilliam R. Sellers · Cambridge, MADirectorNick S. Leschly · Cambridge, MAExec · DirectorWendy S. Dixon · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗